Research Article
Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections
Table 1
Baseline characteristics of newly diagnosed and long-standing T2DM patients.
| | CSII group | MDI3 group | MDI4 group |
| N | n = 39 | n = 38 | n = 39 | L | n = 43 | n = 41 | n = 43 | Age (years) | | | | N | 55.10 ± 10.02 | 52.95 ± 9.63 | 52.56 ± 9.97 | L | 59.68 ± 8.22 | 57.67 ± 10.82 | 58.89 ± 11.85 | Men | | | | N | 19 (49%) | 18 (47%) | 19 (49%) | L | 25 (58%) | 21 (51%) | 23 (53%) | Duration of diabetes (years) | | | | N | No | No | No | L | 12.34 ± 2.07 | 11.33 ± 1.14 | 13.28 ± 2.54 | Body mass index (kg/m2) | | | | N | 24.55 ± 2.90 | 25.72 ± 3.62 | 25.03 ± 2.84 | L | 24.73 ± 3.43 | 25.17 ± 3.29 | 24.66 ± 2.84 | HbA1c (%) | | | | N | 9.65 ± 1.81 | 9.99 ± 1.75 | 10.13 ± 1.93 | L | 8.38 ± 1.68 | 8.18 ± 1.58 | 8.66 ± 1.73 | Systolic blood pressure (mm Hg) | | | | N | 126.77 ± 12.55 | 127.05 ± 16.44 | 131.03 ± 15.56 | L | 129.12 ± 12.76 | 127.41 ± 15.28 | 132.33 ± 11.17 | Diastolic blood pressure (mm Hg) | | | | N | 81.10 ± 9.84 | 81.64 ± 10.15 | 81.25 ± 6.78 | L | 82.72 ± 10.46 | 83.67 ± 11.41 | 83.06 ± 11.10 | Fasting plasma glucose (mmol/L) | | | | N | 10.47 ± 2.62 | 11.07 ± 3.01 | 11.24 ± 2.94 | L | 9.32 ± 2.22 | 8.66 ± 2.75 | 9.56 ± 2.35 | Fasting plasma insulin (mU/L) | | | | N | 5.58 ± 2.95 | 7.40 ± 8.84 | 6.79 ± 2.91 | L | 5.97 ± 2.86 | 6.01 ± 4.19 | 6.11 ± 3.15 | Fasting plasma C-peptide (pmol/L) | | | | N | 2.23 ± 0.77 | 1.98 ± 1.07 | 2.36 ± 1.12 | L | 1.94 ± 0.60 | 2.41 ± 1.11 | 2.02 ± 0.62 |
|
|
Data are mean (SD) or (%). N: newly diagnosed T2DM patients group; L: long-standing T2DM patients group.
|